canyons

Wang Research Lab Publications

Featured Publications

View bibliography for full list of publications.

  1. Cho JM, Park SK, Kwon OS, La Salle DT, Cerbie J, Fermoyle CC, Morgan D, Nelson A, Bledsoe A, Bharath LP, Tandar M, Kunapuli SP, Richardson RS, Anandh Babu PV, Mookherjee S, Kishore BK, Wang F, Yang T, Boudina S, Trinity JD, Symons JD (2022). Activating P2Y1 receptors improves function in arteries with repressed autophagy. Cardiovasc Res. 

  1. Xu C, Yang G, Fu Z, Chen Y, Xie S, Wang F, Yang T (2022). Na+-Retaining Action of COX-2 (Cyclooxygenase-2)/EP1 Pathway in the Collecting Duct via Activation of Intrarenal Renin-Angiotensin-Aldosterone System and Epithelial Sodium Channel Hypertension, HYPERTENSIONAHA12117245. 

  2. Xu C, Chen Y, Wang F, Xie S, Yang T (2021). Soluble (Pro)Renin Receptor as a Negative Regulator of NCC (Na+-Cl- Cotransporter) Activity. Hypertension, 78(4), 1027-1038. 

  3. Wang F, Chen Y, Zou CJ, Luo R, Yang T (2021). Mutagenesis of the Cleavage Site of Pro Renin Receptor Abrogates Angiotensin II-Induced Hypertension in Mice. Hypertension, 78(1), 115-127. 

  1. Fu Z, Wang F, Liu X, Hu J, Su J, Lu X, Lu A, Cho JM, Symons JD, Zou CJ, Yang T (2021). Soluble (pro)renin receptor induces endothelial dysfunction and hypertension in mice with diet-induced obesity via activation of angiotensin II type 1 receptor. Clin Sci (Lond), 135(6), 793-810. 

  1. Feng Y, Peng K, Luo R, Wang F, Yang T (2021). Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II-Induced Hypertension in Mice. Hypertension, 77(2), 405-416. 

  1. Luo R, Yang K, Wang F, Xu C, Yang T (2020). (Pro)renin receptor decoy peptide PRO20 protects against adriamycin-induced nephropathy by targeting the intrarenal renin-angiotensin system. Am J Physiol Renal Physiol, 319(5), F930-F940. 

  1. Wang F, Sun Y, Luo R, Lu X, Yang B, Yang T (2020). COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats. Am J Physiol Renal Physiol, 319 (4), F647-F653. 

  1. Xu C, Wang F, Chen Y, Xie S, Sng D, Reversade B, Yang T (2020). ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury. Am J Physiol Renal Physiol, 318(5), F1122-F1135. 

  1. Wang F, Luo R, Zou CJ, Xie S, Peng K, Zhao L, Yang KT, Xu C, Yang T (2020). Soluble (pro)renin receptor treats metabolic syndrome in mice with diet-induced obesity via interaction with PPARγ. JCI Insight, 5(7). 

  1. Wang F, Luo R, Peng K, Liu X, Xu C, Lu X, Soodvilai S, Yang T (2020). Soluble (pro)renin receptor regulation of ENaC involved in aldosterone signaling in cultured collecting duct cells. Am J Physiol Renal Physiol, 318(3), F817-F825. 

  1. Wang F, Xu C, Luo R, Peng K, Ramkumar N, Xie S, Lu X, Zhao L, Zuo CJ, Kohan DE, Yang T (2019). Site-1 protease-derived soluble (pro)renin receptor targets vasopressin receptor 2 to enhance urine concentrating capability. JCI Insight, 4(7). 

  1. Liu M, Deng M, Su J, Lin Y, Jia Z, Peng K, Wang F, Yang T (2018). Specific downregulation of cystathionine β-synthase expression in the kidney during obesity. Physiol Rep, 6(13), e13630. 

Why Utah?